Clinical trials: Progressive Supranuclear Palsy Richardson Syndrome (PSP-RS)
- Condition Progressive Supranuclear Palsy Richardson Syndrome (PSP-RS)
- Funder type Industry (pharma, biotech, devices)
- Accepts healthy volunteers yes
Progressive Supranuclear Palsy
Test-retest Study With [18F]PI-2620 in PSP-RS and NDC
The overall goal of this protocol is to evaluate the imaging characteristics of [18F]PI-2620 using positron emission tomography (PET) in patients with progressive supranuclear palsy, Richardson's syndrome (PSP-RS)
- Trial name
- NCT05187546
- Testing
- [18F]-PI2620
- Where
- Germany
- Volunteers
- 15 people, healthy volunteers welcome
- Sponsor
- Life Molecular Imaging GmbH